Clinical trial

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

NCT04371042

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2019-09-01

PhaseN/A

Conditions

NAFLD - Nonalcoholic Fatty Liver Diseaseverified · MONDO: metabolic dysfunction-associated steatotic liver disease

Diabetesverified · MONDO: diabetes mellitus

Obesityverified · MONDO: obesity disorder

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Cirrhosisverified · MONDO: cirrhosis of liver

Liver Cancerverified · MONDO: liver cancer

NASH - Nonalcoholic Steatohepatitisverified · MONDO: metabolic dysfunction-associated steatohepatitis

HCC - Hepatocellular Carcinomaunresolved

Fatty Liververified · MONDO: fatty liver disease

Interventions

Sponsors & collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCSlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04371042 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.